Samuel Friedlander, MD
Allergy & Immunology · Solon, OHNPI 1689630345
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $74,183 of the $100,267 with a category attached, or 74.0%. 27 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 49.3% of the total. Reporting peaked in 2021 at $36,729 and has fallen 91.9% since, to $2,985 in 2025. Among allergy & immunology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 368 payments — averaging $272.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$49K
- Optinose US, Inc.$47K
- GSK$570
- AstraZeneca$564
- Novartis$338
- Alk-abello, Inc$313
- plus $2K from 21 others
What the payments were for
- Consulting fees$14,56315%
- Speaking & faculty fees$74,18374%
- Travel & lodging$4,4094%
- Food & beverage$7,1127%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 92 | $49,460 |
| Optinose US, Inc. | 113 | $47,458 |
| GSK | 50 | $570 |
| AstraZeneca | 20 | $564 |
| Novartis | 6 | $338 |
| Alk-abello, Inc | 7 | $313 |
| Genentech USA, Inc. | 13 | $272 |
| Jazz Pharmaceuticals Inc. | 8 | $158 |
| Pharming Healthcare, Inc. | 8 | $130 |
| CSL Behring | 6 | $124 |
| Kaleo, Inc. | 8 | $119 |
| Harmony Biosciences LLC | 4 | $110 |
| Sanofi | 4 | $90 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $90 |
| Greer Laboratories, Inc. | 3 | $68 |
| Amgen(2 entities) | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Biocryst Pharmaceuticals, Inc. | 3 | $46 |
| Pfizer | 2 | $35 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Jubilant Hollisterstier LLC | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Biocryst US Sales Co., LLC | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| 3b Medical, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$45,773
- CINQAIR$25,756
- ProAir Digihaler$13,880
- AirDuo RespiClick$13,880
- ArmonAir Digihaler$13,880
- Odactra$235
- Ragwitek$235
- Grastek$235
- TEZSPIRE$104
How this compares
$100,267 in reported general payments places this provider in the 90th percentile of 128 allergy & immunology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 12 | $38,568 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $25,563 |
| XhanceFluticasone Propionate | 15 | $9,122 |
| DuleraMometasone/Formoterol | 23 | $8,143 |
| Epinephrine | 37 | $6,711 |
| Wixela InhubFluticasone Propion/Salmeterol | 58 | $6,620 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $5,811 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,742 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 77 | $4,698 |
| Fluticasone Propionate | 202 | $3,073 |
| Azelastine Hcl | 97 | $2,949 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 82 | $1,983 |
| Ipratropium Bromide | 66 | $1,952 |
| AsmanexMometasone Furoate | 12 | $1,866 |
| Proair RespiclickAlbuterol Sulfate | 18 | $1,181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $570 | $30,30541 claims |
| Optinose US, Inc.Xhance | $47,458 | $9,12215 claims |
| Hikma Pharmaceuticals USAEpinephrine | $35 | $6,71137 claims |
| Teva Pharmaceuticals USA, Inc.Proair Respiclick | $49,460 | $1,18118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 128 allergy & immunology providers in Ohio.
Other allergy & immunology in Solon
- Justin GreiweCincinnati$1M
- Jonathan BernsteinCincinnati$810K
- Adam UpdegraffToledo$379K
- Syed RehmanToledo$374K
- Gordon MyersCincinnati$346K
- Nancy Wasserbauer KingstonRocky River$256K
- David LangCleveland$251K
- James FernandezCleveland$179K
- Donald McNeilColumbus$136K
- Amber PattersonFindlay$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.